....An AstraZeneca spokeswoman said the move was “part of our ongoing investment in the UK”. Mene Pangalos, who runs its innovative medicines and early development biotech
unit, is expected to announce the firm’s plans in Birmingham. ...
[Read full article on Guardian
Sunday 27th of August 2017 01:31:50 PM